P120 Catenin Isoforms Differentially Associate with Breast Cancer Invasion and Metastasis.
Jan-Hendrik VenhuizenPaul N SpanKoen van den DriesSebastian SommerPeter FriedlMirjam M P ZegersPublished in: Cancers (2019)
Tumor metastasis is the endpoint of tumor progression and depends on the ability of tumor cells to locally invade tissue, transit through the bloodstream and ultimately to colonize secondary organs at distant sites. P120 catenin (P120) has been implicated as an important regulator of metastatic dissemination because of its roles in cell-cell junctional stability, cytoskeletal dynamics, growth and survival. However, conflicting roles for P120 in different tumor models and steps of metastasis have been reported, and the understanding of P120 functions is confounded by the differential expression of P120 isoforms, which differ in N-terminal length, tissue localization and, likely, function. Here, we used in silico exon expression analyses, in vitro invasion assays and both RT-PCR and immunofluorescence of human tumors. We show that alternative exon usage favors expression of short isoform P120-3 in 1098 breast tumors and correlates with poor prognosis. P120-3 is upregulated at the invasive front of breast cancer cells migrating as collective groups in vitro. Furthermore, we demonstrate in histological sections of 54 human breast cancer patients that P120-3 expression is maintained throughout the metastatic cascade, whereas P120-1 is differentially expressed and diminished during invasion and in metastases. These data suggest specific regulation and functions of P120-3 in breast cancer invasion and metastasis.
Keyphrases
- poor prognosis
- long non coding rna
- cell migration
- endothelial cells
- squamous cell carcinoma
- small cell lung cancer
- single cell
- cell proliferation
- breast cancer cells
- cell therapy
- epithelial mesenchymal transition
- induced pluripotent stem cells
- stem cells
- transcription factor
- pluripotent stem cells
- high throughput
- escherichia coli
- young adults
- multidrug resistant
- bone marrow
- gram negative
- free survival